CD4 and Parkinson disease: In addition, studies by He et al. [53] have found that compared to healthy controls (HCs) unaffected by Parkinson’s disease (PD) medications, PD patients show an increase in quantities of late-differentiated CD4+ T-cells (CD3+CD4+CD28−CD27−).